Most individuals affected by schizophrenia manifest negative symptoms. Because negative symptoms have a persistent deleterious effect on the social and vocational performance of the affected individuals, investigators in academia and pharmaceutical industry are making efforts to develop treatments for this condition. To be successful basic science must expand beyond attempts to interfere with the brain dopaminergic activity and clinical science must improve trials methodology.
No takes yet. Share an insight, caveat, or question.
Luthringer et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: